Concepedia

Minglian Xu

MX

Statistics

Publications

4

Citations

78

H-Index

4

Active since

2023

Affiliations

Guangxi Medical University(Current)

First Affiliated Hospital of GuangXi Medical University

Shenzhen Institutes of Advanced Technology

Chinese Academy of Sciences

The University of Western Australia

Minglian Xu is an author at Guangxi Medical University specializing in bone metabolism, rankl-mediated osteoclastogenesis, and osteoclast biology.

Publications per year

2023–2024

4

Publications

4

Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways

Yiwu Qin, Dezhi Song, Shijie Liao et al. · Biomedicine & Pharmacotherapy · 2023 · 34 citations · Full text

, , +17

IKK/NF‐κB and ROS signal axes are involved in Tenacissoside H mediated inhibitory effects on LPS‐induced inflammatory osteolysis

Xiaoxiao Xie, Weiwei Chen, Minglian Xu et al. · Cell Proliferation · 2023 · 19 citations · Full text

, , +16

Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROS

Jian Huang, Dezhi Song, Minglian Xu et al. · Phytotherapy Research · 2024 · 14 citations

, , +15

CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca2+ oscillations and NF-κB/MAPK signaling pathways

Minglian Xu, Dezhi Song, Xiaoxiao Xie et al. · iScience · 2023 · 11 citations · Full text

, , +17

1–4 of 4